Use of Albuterol Multidose Dry Powder Inhaler in Participants With Chronic Obstructive Pulmonary Disease

- Chronic Obstructive Pulmonary Disease
- Completed

Study Title: Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Teva Identifier: ABS-COPD-30065

ClinicalTrials.gov Identifier: NCT03256695

Study Status: Completed

Trial Condition(s): Chronic Obstructive Pulmonary Disease

Interventions: Drug: Albuterol sulfate (ABS)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 40 Years and older

Trial Duration: September 28, 2017 - April 17, 2018

Phase: Phase 3

Study Type

Interventional